Janssen receives two u.s. fda approvals for simponi aria ® (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis

SIMPONI ARIA ® is the Only Fully-Human Anti-TNF-alpha Infused Therapy Now Approved for Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news